MetaADEDB 2.0 @ LMMD
sumatriptan-naproxen
(IGRAQVLKCQVBQA-DBQHITQZSA-M)
Structure
SMILES
OC(=O)CCC(=O)O.CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2.COc1ccc2c(c1)ccc(c2)[C@@H](C(=O)[O-])C.[Na+]
Molecular Formula:
C32H40N3NaO9S
Molecular Weight:
665.729
Log P:
4.4305
Hydrogen Bond Acceptor:
11
Hydrogen Bond Donor:
4
TPSA:
197.54
CAS Number(s):
811794-26-0
Synonym(s)
1.
sumatriptan-naproxen
2.
Treximet
External Link(s)
MeSHC000611385
PubChem Compound23709079
Therapeutic Target DatabaseD07NJI
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 47US FAERS
2Drug ineffectiveFAERS: 38US FAERS
3DizzinessFAERS: 29US FAERS
4VomitingFAERS: 24US FAERS
5Chest PainFAERS: 21US FAERS
6Chest discomfortFAERS: 17US FAERS
7HeadacheFAERS: 16US FAERS
8Burning sensationFAERS: 15US FAERS
9PalpitationsFAERS: 15US FAERS
10HypersensitivityFAERS: 14US FAERS
11MalaiseFAERS: 14US FAERS
12Feeling abnormalFAERS: 13US FAERS
13MyalgiaFAERS: 12US FAERS
14AnxietyFAERS: 11US FAERS
15DyspepsiaFAERS: 9US FAERS
16Drug administration errorFAERS: 8US FAERS
17Muscle tightnessFAERS: 8US FAERS
18PainFAERS: 8US FAERS
19Myocardial InfarctionFAERS: 7US FAERS
20Neck PainFAERS: 7US FAERS
21Nonspecific reactionFAERS: 7US FAERS
22SomnolenceFAERS: 7US FAERS
23Adverse eventFAERS: 6US FAERS
24ArthralgiaFAERS: 6US FAERS
25FatigueFAERS: 6US FAERS
26Product quality issueFAERS: 6US FAERS
27PruritusFAERS: 6US FAERS
28TremorFAERS: 6US FAERS
29UrticariaFAERS: 6US FAERS
30Abdominal discomfortFAERS: 5US FAERS
31AgeusiaFAERS: 5US FAERS
32OverdoseFAERS: 5US FAERS
33Stevens-Johnson SyndromeFAERS: 5US FAERS
34SwellingFAERS: 5US FAERS
35AstheniaFAERS: 4US FAERS
36FlushingFAERS: 4US FAERS
37Musculoskeletal PainFAERS: 4US FAERS
38Nasal discomfortFAERS: 4US FAERS
39Wrong technique in drug usage processFAERS: 4US FAERS
40AsthmaFAERS: 3US FAERS
41CyanosisFAERS: 3US FAERS
42GastritisFAERS: 3US FAERS
43Impaired work abilityFAERS: 3US FAERS
44Lip swellingFAERS: 3US FAERS
45Oropharyngeal painFAERS: 3US FAERS
46Unevaluable eventFAERS: 3US FAERS
47Abdominal PainFAERS: 2US FAERS
48Acute myocardial infarctionFAERS: 2US FAERS
49Angina PectorisFAERS: 2US FAERS
50Back PainFAERS: 2US FAERS
51Cold sweatFAERS: 2US FAERS
52DiscomfortFAERS: 2US FAERS
53DisorientationFAERS: 2US FAERS
54ErythemaFAERS: 2US FAERS
55Feeling jitteryFAERS: 2US FAERS
56Mental impairmentFAERS: 2US FAERS
57Musculoskeletal discomfortFAERS: 2US FAERS
58Musculoskeletal stiffnessFAERS: 2US FAERS
59NervousnessFAERS: 2US FAERS
60Performance status decreasedFAERS: 2US FAERS
61Prescribed overdoseFAERS: 2US FAERS
62Serotonin SyndromeFAERS: 2US FAERS
63Skin lesionFAERS: 2US FAERS
64Therapeutic response delayedFAERS: 2US FAERS
65Throat irritationFAERS: 2US FAERS
66UlcerFAERS: 2US FAERS
67AbasiaFAERS: 1US FAERS
68Accidental overdoseFAERS: 1US FAERS
69AgitationFAERS: 1US FAERS
70Allergic respiratory symptomFAERS: 1US FAERS
71AngioedemaFAERS: 1US FAERS
72AphagiaFAERS: 1US FAERS
73Blood glucose decreasedFAERS: 1US FAERS
74Blood urine presentFAERS: 1US FAERS
75Bone painFAERS: 1US FAERS
76Breast tendernessFAERS: 1US FAERS
77Cardiac enzymes increasedFAERS: 1US FAERS
78CryingFAERS: 1US FAERS
79DehydrationFAERS: 1US FAERS
80Depressed Level of ConsciousnessFAERS: 1US FAERS
81DiverticulumFAERS: 1US FAERS
82Dreamy stateFAERS: 1US FAERS
83Drug abuseFAERS: 1US FAERS
84Drug screen positiveFAERS: 1US FAERS
85DysarthriaFAERS: 1US FAERS
86DysgraphiaFAERS: 1US FAERS
87Ejection Fraction DecreasedFAERS: 1US FAERS
88EnteritisFAERS: 1US FAERS
89Expired drug administeredFAERS: 1US FAERS
90Eye painFAERS: 1US FAERS
91Eyelid painFAERS: 1US FAERS
92Facial ParesisFAERS: 1US FAERS
93Gastric ulcerFAERS: 1US FAERS
94Genital painFAERS: 1US FAERS
95HyperventilationFAERS: 1US FAERS
96Hypoaesthesia facialFAERS: 1US FAERS
97HypotensionFAERS: 1US FAERS
98Impaired driving abilityFAERS: 1US FAERS
99Incorrect dose administeredFAERS: 1US FAERS
100Incorrect drug administration durationFAERS: 1US FAERS
101Incorrect drug dosage form administeredFAERS: 1US FAERS
102Mastication disorderFAERS: 1US FAERS
103Medication ErrorFAERS: 1US FAERS
104Medication overuse headacheFAERS: 1US FAERS
105Middle insomniaFAERS: 1US FAERS
106MonoplegiaFAERS: 1US FAERS
107Muscle FatigueFAERS: 1US FAERS
108MydriasisFAERS: 1US FAERS
109No adverse eventFAERS: 1US FAERS
110Oropharyngeal discomfortFAERS: 1US FAERS
111Pityriasis RoseaFAERS: 1US FAERS
112Post-Traumatic Stress DisorderFAERS: 1US FAERS
113Product label issueFAERS: 1US FAERS
114Product physical issueFAERS: 1US FAERS
115Rash erythematousFAERS: 1US FAERS
116Renal painFAERS: 1US FAERS
117Respiratory arrestFAERS: 1US FAERS
118Serum SicknessFAERS: 1US FAERS
119SinusitisFAERS: 1US FAERS
120SyncopeFAERS: 1US FAERS
121TachycardiaFAERS: 1US FAERS
122Tension HeadacheFAERS: 1US FAERS
123Therapeutic response changedFAERS: 1US FAERS
124Therapeutic response unexpectedFAERS: 1US FAERS
125Therapy cessationFAERS: 1US FAERS
126TinnitusFAERS: 1US FAERS
127Toxicity to various agentsFAERS: 1US FAERS
128TrismusFAERS: 1US FAERS
129VasospasmFAERS: 1US FAERS
130VertigoFAERS: 1US FAERS
131Weight decreasedFAERS: 1US FAERS
132Wrong technique in product usage processFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.